Renal prognoses by different target hemoglobin levels achieved by epoetin beta pegol dosing to chronic kidney disease patients with hyporesponsive anemia to erythropoiesis-stimulating agent: a multicenter open-label randomized controlled study
2020 ◽
Vol 59
(8)
◽
pp. 955-961
◽
2016 ◽
Vol 37
(27)
◽
pp. 2105-2114
◽
2017 ◽
Vol 32
(suppl_3)
◽
pp. iii219-iii219
2020 ◽
Vol 30
(3)
◽
pp. 200-207
◽